Sudden change from skewed distributions. by Ariel Burman (20329776)

Expression of mAChR M1, M2, M3, M4, and M5 mRNA in the mid colon. by Ji Eun Kim (403026)

Aberrant CpG methylation of the <i>TFAP2A</i> gene constitutes a mechanism for loss of <i>TFAP2A</i> expression in human metastatic melanoma by Andrea R Hallberg (686570)

“…Among these, a gene implicated in several steps of melanocyte development, <i>TFAP2A</i>, is frequently silenced; however, the molecular mechanism of <i>TFAP2A</i> silencing in human melanoma remains unknown. …”

Characterization of recent and minimally passaged Brazilian dengue viruses inducing robust infection in rhesus macaques by Maria Beatriz Borges (5142965)

Cardamonin inhibited the proliferation of ovarian cancer cells. by Peiguang Niu (17044532)

Upstream regulators for thyroid and plasma using IPA. by Malin Larsson (1616557)

Association between the posterior part of the circle of Willis and the vertebral artery hypoplasia by Virginija Gaigalaite (7378229)

“…With the increasing degree of VAH, the proportion of FCW increases, while the proportion of absence/hypoplastic of both PCoA decreases.</p></div>…”

Effect of BoNT/B and TeTx on VAMP2 Immunofluorescence by Gerardo A. De Blas (262394)

“…In contrast, when cells were first allowed to arrive at the intra-acrosomal Ca²⁺-sensitive step and then treated with toxins, BoNT/B caused a significant decrease of the VAMP2 label (asterisks, [J]), whereas TeTx had no effect (S). …”

Mitochondrial superoxide production and MMP. by Kaytee L. Pokrzywinski (3605435)

A Reduce and Replace Strategy for Suppressing Vector-Borne Diseases: Insights from a Stochastic, Spatial Model by Kenichi W. Okamoto (500514)

“…We find this “reduce and replace” strategy can decrease the frequency of competent vectors below 50% two years after releases end. …”

Purification and Characterization of the Fe^II- and α-Ketoglutarate-Dependent Xanthine Hydroxylase from <i>Aspergillus nidulans</i>^† by Gabriela M. Montero-Morán (2493271)

“…The αKG cosubstrate can be substituted with α-ketoadipate (9-fold decrease in <i>k</i>_cat and 5-fold increase in the <i>K</i>_m compared to those of the normal α-keto acid), while the αKG analogue <i>N</i>-oxalylglycine is a competitive inhibitor (<i>K</i>_i = 0.12 μM). …”

Repeat the detection experiment. by Yingying Liu (360782)

Schematic of the control loop. by Lorenzo Fruzzetti (13905975)

“…For each error range, the effect of the related IO’s firing probability (producing an LTD in PF-PC synapses), and the error-independent LTP on the two PC subpopulations is showed. If the arrow points down the overall PF-PC weight decreases due to dominant LTD process, decreasing the firing rate of the PCs on subsequent trials, if the arrow points up then the resulting weight change is positive due to dominant LTP process, increasing the PC firing rate on subsequent trials.…”

Organic Cation Alloying on Intralayer A and Interlayer A’ sites in 2D Hybrid Dion–Jacobson Lead Bromide Perovskites (A’)(A)Pb₂Br₇ by Lingling Mao (513927)

<i>chb-3</i> encodes a novel protein with a zf-MYND motif. by Manabi Fujiwara (236721)

“…Y50C1, Y2F4 (<i>C. elegans</i> genomic YAC clone), and a Y48G1A.3 PCR fragment (6.5 kb) which contained the Y48G1A.3 predicted gene and 1 kb of upstream sequence, rescued the Daf-c phenotype of <i>chb-3(eg52)</i>. …”

Data_Sheet_1_Ribozyme-Mediated Downregulation Uncovers DNA Integrity Scanning Protein A (DisA) as a Solventogenesis Determinant in Clostridium beijerinckii.pdf by Victor Chinomso Ujor (10939044)

“…To relieve CCR in Clostridium beijerinckii NCIMB 8052, we sought to downregulate catabolite control protein A (CcpA) using the M1GS ribozyme technology. …”

Data_Sheet_1_Small Molecule Inhibitor Adjuvant Surfactant Therapy Attenuates Ventilator- and Hyperoxia-Induced Lung Injury in Preterm Rabbits.pdf by Pragnya Das (8692077)

Therapeutic efficacy of Clrn1 re-expression in Müller glia depends on expression level. by Hannah J. T. Nonarath (20861735)

“…Error bars=SD. Scale Bar = 50 µm. n=8-12 larvae for each genotype per condition.…”

Table_3_Vitamin A deficiency in the MENA region: a 30-year analysis (1990–2019).DOCX by Saeid Safiri (3713035)

“…The age-standardized prevalence [50.3% (−55.9 to −44.7)] and YLD [−49.3% (−55.3 to −43.1)] rates of VAD have significantly decreased since 1990. …”

Table_2_Vitamin A deficiency in the MENA region: a 30-year analysis (1990–2019).DOCX by Saeid Safiri (3713035)

“…The age-standardized prevalence [50.3% (−55.9 to −44.7)] and YLD [−49.3% (−55.3 to −43.1)] rates of VAD have significantly decreased since 1990. …”